| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |